Advisory Services Network’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,091
Closed -$69K 1887
2021
Q2
$69K Sell
1,091
-5,273
-83% -$339K ﹤0.01% 1819
2021
Q1
$591K Sell
6,364
-220
-3% -$22.5K 0.02% 778
2020
Q4
$590K Buy
6,584
+5,529
+524% +$507K 0.02% 680
2020
Q3
$109K Buy
+1,055
New +$114K 0.01% 1217
2020
Q2
Sell
-305
Closed -$18K 1458
2020
Q1
$18K Buy
305
+200
+190% +$11.5K ﹤0.01% 1914
2019
Q4
$6K Hold
105
﹤0.01% 2544
2019
Q3
$5K Hold
105
﹤0.01% 2395
2019
Q2
$5K Buy
+105
New +$5.03K ﹤0.01% 2393
2019
Q1
Sell
-143
Closed -$9K 2558
2018
Q4
$9K Buy
143
+124
+653% +$7.99K ﹤0.01% 1788
2018
Q3
$1K Hold
19
﹤0.01% 2379
2018
Q2
$1K Hold
19
﹤0.01% 2344
2018
Q1
$1K Buy
+19
New +$947 ﹤0.01% 2461
2016
Q3
$2K Sell
50
-50
-50% -$1.45K ﹤0.01% 1772
2016
Q2
$3K Buy
+100
New +$3.92K ﹤0.01% 1545

Other funds holding EBS

Advisory Services Network's EBS Position: Q3 2021 in Review

Advisory Services Network sold out of Emergent Biosolutions (EBS) in Q3 2021, closing a stake of 1,091 shares — an estimated $69K sold.

Advisory Services Network first reported a position in EBS in Q2 2016 and held it in 14 quarters. The position peaked at $591K in Q1 2021. 277 funds tracked by Wall St. Rank hold EBS as of Q3 2021.

  • Advisory Services Network reported no remaining Emergent Biosolutions position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 1,091 Emergent Biosolutions shares in Q3 2021, an estimated $69K.
  • Advisory Services Network first reported a position in Emergent Biosolutions in Q2 2016 and held it in 14 quarters.
  • Advisory Services Network's Emergent Biosolutions position peaked at $591K in Q1 2021.
  • 277 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.